Related references
Note: Only part of the references are listed.Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats
Yoshihiro Kuno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Effects of Phosphodiesterase Inhibitors on the Inflammatory Response of Endothelial Cells Stimulated by Myeloperoxidase-Modified Low-Density Lipoprotein or Tumor Necrosis Factor Alpha
Thierry Roumeguere et al.
EUROPEAN UROLOGY (2010)
Effects of Sildenafil on Oxidative and Inflammatory Injuries of the Kidney in Streptozotocin-Induced Diabetic Rats
Kyung-Hwan Jeong et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy
Kristof Hirschberg et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Mechanical forces and TGFβ1 reduce podocyte adhesion through α3β1 integrin downregulation
Cecile Dessapt et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Gene expression patterns in glucose-stimulated podocytes
Seung Hyeok Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
J. A. Jefferson et al.
KIDNEY INTERNATIONAL (2008)
PDE-5 inhibition impedes TSP-1 expression, TGF-β activation and matrix accumulation in experimental glomerulonephritis
Bernd Hohenstein et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats
Grzegorz Piecha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Effect of chronic administration of sildenafil on sodium retention and on the hemodynamic complications associated with liver cirrhosis in the rat
Rana Ghali-Ghoul et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Sildenafil improves immediate posttransplant parameters in warm-ischemic kidney transplants: Experimental study
E. Lledo-Garcia et al.
TRANSPLANTATION PROCEEDINGS (2007)
Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat
Sarah Knight et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice
Hui John Zhao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
TGF-β concentration specifies differential signaling profiles of growth arrest/differentiation land apoptosis in podocytes
DT Wu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage
B Rodríguez-Iturbe et al.
KIDNEY INTERNATIONAL (2005)
Sildenafil inhibits the formation of superoxide and the expression of gp47phox NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells
AJ Koupparis et al.
BJU INTERNATIONAL (2005)
From the periphery of the glomerular capillary wall toward the center of disease - Podocyte injury comes of age in diabetic nephropathy
G Wolf et al.
DIABETES (2005)
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications
G Wolf et al.
KIDNEY INTERNATIONAL (2005)
Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats
E Milani et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2005)
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies
P Pacher et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-β activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2
SX Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Early glomerular filtration defect and severe renal disease in podocin-deficient mice
S Roselli et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Diabetic nephropathy and transforming growth factor-β:: Transforming our view of glomerulosclerosis and fibrosis build-up
S Chen et al.
SEMINARS IN NEPHROLOGY (2003)
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes - A multicenter double-blind placebo-controlled fixed-dose study
I Goldstein et al.
DIABETES CARE (2003)
Transforming growth factor-β1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins -: A central pathway in progressive glomerulosclerosis
M Abbate et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Effects of high glucose and TGF-β1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes
MC Iglesias-de la Cruz et al.
KIDNEY INTERNATIONAL (2002)
Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency
ND Vaziri et al.
HYPERTENSION (2002)
High glucose-induced hypertrophy of mesangial cells requires p27Kip1, an inhibitor of cyclin-dependent kinases
G Wolf et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death
H Putaala et al.
HUMAN MOLECULAR GENETICS (2001)
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice
FN Ziyadeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
